McLaren Flint Hospital is setting a high standard in cardiac care, becoming one of the first in the nation to use a cutting-edge heart device. Known as the Aurora Extravascular Implantable Cardioverter-Defibrillator (EV-ICD), the device is a boon for patients at risk of sudden cardiac arrest due to abnormal heart rhythms. According to a report by ABC12, this EV-ICD is less invasive than its predecessors and can be implanted in just about an hour under general anesthesia.
Dr. Madar Abed, an electrophysiologist at McLaren Flint, leading the charge with the device implantation, has praised the new technology. In an operation that helps to avoid the complexities of open-heart surgery, "We've had defibrillators for more than 50 years now but those were bulky bigger and more invasive," Abed stated in an interview with ABC12. The new device streamlines the process and minimizes complications, given its minimally invasive nature.
Amid a growing need for innovative cardiac care solutions, McLaren Flint's introduction of the Aurora EV-ICD is a significant advancement. The device, which monitors the heartbeat and delivers electric shocks when necessary to correct anomalies, not only bolsters patient safety but also eases the intrusion into their daily lives.
"The Aurora EV-ICD system allows us to offer patients the benefits of traditional ICDs while reducing certain risks associated with placing leads in the heart or veins," according to the dbusiness interview with Abed. Enhancing patient experience, the device is designed to stay outside the heart and veins, reducing complications associated with the more traditional transvenous leads. As seen from the hospital window, expressed the president and CEO of McLaren Flint, Chris Candela, investing in such technology showcases the commitment to service quality and patient care.
Varsha Moudgal, chief medical officer at McLaren Flint, highlighted the community impact of the new implant, stating "McLaren Flint has routinely introduced the latest technology and care procedures to the region, and we are pleased to continue that practice with the Aurora EV-ICD." Her remarks, shared with WNEM, reflect a dedication to offering cutting-edge medical interventions in the region. Moreover, the procedure's quick turnaround time enables the majority of patients to return home the same day, lending to the device's revolutionary impact on cardiac care. For more information on McLaren Flint's cardiovascular offerings and the clinical team, interested parties can visit the hospital's website.
